About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Alembic Pharmaceuticals Ltd.
BSE Code
533573
ISIN Demat
INE901L01018
Book Value
264.28
NSE Code
APLLTD
Dividend Yield %
1.13
Market Cap
190980.73
P/E
37.96
EPS
25.60
Face Value
2
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
25-Jun-2025
949.20
973.25
946.50
971.60
2238
2152046
24-Jun-2025
967.85
967.85
935.05
947.05
7280
6850512
23-Jun-2025
942.05
946.55
923.15
938.95
7074
6598220
20-Jun-2025
972.90
972.90
923.30
940.65
3693
3459952
19-Jun-2025
973.95
973.95
930.00
931.80
6902
6508044
18-Jun-2025
982.00
982.00
952.85
958.90
11858
11400619
17-Jun-2025
979.25
979.25
962.50
970.25
9885
9602073
16-Jun-2025
997.65
997.65
967.00
970.15
9999
9762992
13-Jun-2025
987.70
1004.15
980.45
999.30
3525
3474990
12-Jun-2025
1000.00
1040.25
986.80
990.75
4317
4401984
11-Jun-2025
983.70
1000.65
976.35
995.90
4512
4477760
10-Jun-2025
1014.95
1014.95
978.05
982.85
3741
3678789
09-Jun-2025
956.05
992.40
956.05
989.55
2665
2626308
06-Jun-2025
970.05
989.90
970.05
987.85
2169
2132172
05-Jun-2025
999.00
999.00
971.00
972.85
2453
2400644
04-Jun-2025
989.00
989.00
969.15
981.60
1942
1903732
03-Jun-2025
994.80
996.00
962.50
964.85
3558
3492356
02-Jun-2025
1017.40
1017.40
990.00
994.40
7347
7354971
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.